Medrio is on a mission to ease complexity in today’s hybrid, decentralized, and site-based clinical trials by delivering a flexible suite of eClinical technologies and services, including EDC, eCOA, ePRO, eConsent, Direct Data Capture, and Randomization and Trial Supply Management (RTSM). Trusted by contract research organizations (CROs), sponsors, and sites across all therapeutic areas and trial phases from study startup and feasibility to post-market approval since 2005, Medrio is industry-recognized for delivering eClinical software with intuitive interfaces and time-saving “drag and drop” configurations as well as high-touch customer engagement, onboarding, and support services.


IP scarcity can derail a clinical trial. Incorporating randomization and supply management best practices into your study design ensures clinicians will have access to the product they need, budgets are properly managed, and participant privacy is protected.

Medrio empowers you to elevate your clinical trial with a Randomization and Trial Supply Management (RTSM) platform. Stay in control of your study with real-time insight into participant status, IP supply, and shipment information.




  • What makes a clinical trials software provider a good fit? How do you make the decision to use a particular electronic data capture (EDC) system or electronic patient reported outcome (ePRO) solution? Learn how the answers are different for every sponsor and contract research organization (CRO).

  • Find out how the Digital Medicine Society (DiMe), an interdisciplinary professional society for digital medicine, was able to deploy an eConsent module in less than two weeks to support its remote study to assess nocturnal scratching as an endpoint for patients.

  • In a proof-of-concept for a decentralized hybrid study, explore how Electronic Patient-Reported Outcomes (ePRO) technology was used to assess the results of varying digital therapies and the feasibility of conducting a largely virtual clinical study in a fibromyalgia population.

  • Delve into how the TargetCancer Foundation implemented a remote consent function in their TCF-001 TRACK study with an objective to determine if rare tumors can benefit from matched molecular therapy.

  • Sciformix, an SPO (Scientific Process Organization) serving a diverse variety of clinical trials across all phases, has built substantial experience in Medrio in a short span of time. Find out how Medrio helped Sciformix reduce the cost and timeline of the study.


  • Discover the ways in which a patient-centric approach can remove controllable barriers from the clinical trial process and strengthen patient engagement.

  • Reducing the number of vendors you interact with allows you to not only achieve higher quality data, you can also spend more time focusing on what matters- the patients. Our fully integrated RTSM and EDC allows you to spend more time focused on your data and less on outside programmers and vendors. In this episode we will explore the value of a combined solution and what you can expect in return.